UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Government should control next-generation sequencing data’
by Kim Yun-mi
2020-01-20 15:47
Pfizer’s spinoff of generics unit causes disputes with trade union
by Kim Yun-mi
2020-01-20 15:44
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
by Kim Yun-mi
2020-01-17 17:30
GSK to target ovarian cancer, multiple myeloma, endometrial cancer
by Kim Yun-mi
2020-01-16 14:10
Regulator to mandate long-term follow-up on advanced biopharmaceuticals
by Kim Yun-mi
2020-01-15 13:05
라인
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
by Kim Yun-mi
2020-01-14 15:28
Zejula widens indication as monotherapy for ovarian cancer
by Kim Yun-mi
2020-01-13 16:25
Lilly secures atopic dermatitis drug through Dermira acquisition
by Kim Yun-mi
2020-01-13 14:05
Latecomer Bavencio improves overall survival in bladder cancer trial
by Kim Yun-mi
2020-01-10 14:23
Regulator to help Korean firms’ global biz through international cooperation
by Kim Yun-mi
2020-01-08 16:33
라인
Eliquis price cut delayed amid prolonged administrative suit
by Kim Yun-mi
2020-01-07 11:32
BioMarin seeks license for gene therapy to treat hemophilia
by Kim Yun-mi
2020-01-06 16:44
Tau, rather than amyloid, may cause Alzheimer’s disease
by Kim Yun-mi
2020-01-06 14:13
[New Year Special] Investors vulnerable to risky biotech business
by Kim Yun-mi
2020-01-02 17:35
Multinational pharmaceuticals' rush to merge face union backlash in Korea
by Kim Yun-mi
2019-12-29 10:54
라인
‘No-Japan’ campaign cause anxiety among Japanese pharmaceutical firms
by Kim Yun-mi
2019-12-27 12:08
Migraine drug market heats up with Ubrelvy’s arrival
by Kim Yun-mi
2019-12-27 11:57
Dupixent to get coverage from January
by Kim Yun-mi
2019-12-24 15:40
‘Korea still slow to expand benefit for new drugs’
by Kim Yun-mi
2019-12-24 15:37
Vitamin E acetate likely cause of lung injuries from vaping
by Kim Yun-mi
2019-12-23 15:02
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top